Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 06 - 17 symbols : SNY save search
$10+ Billion Blood Glucose Monitoring Devices Global Market to 2026 - Increasing Awareness About Point of Care Testing Presents Opportunities
Published: 2021-06-17 (Crawled : 21:00) - prnewswire.com
MDT | $80.38 -1.12% -0.03% 5M
|
Health Technology
|
| O: -1.29%
H: 0.62%
C: -0.29%
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: -1.18%
H: 0.56%
C: -0.79%
FMC A | $58.4 -0.43% 0.33% 1M
|
Process Industries
|
| O: -1.33%
H: 0.4%
C: -3.77%
LLY | News | $732.2 -1.81% -0.84% 1.7M
|
Health Technology
|
| O: -0.8%
H: 0.28%
C: -0.85%
ABT | News | $106.89 -0.65% -0.09% 4.2M
|
Health Technology
|
| O: -1.46%
H: 1.23%
C: 0.3%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -1.9%
H: 1.38%
C: 1.21%
DXCM | $137.87 2.89% 2.8% 2.4M
|
Health Technology
|
| O: -0.13%
H: 1.77%
C: 1.55%
blood test device
Global Mycosis Fungoides Market (2021 to 2029) - Featuring Bayer, Elorac and Sanofi Among Others
Published: 2021-06-17 (Crawled : 21:00) - prnewswire.com
SNGX | $0.383 -4.25% -3.9% 480K
|
Health Technology
|
| O: -1.67%
H: 0.85%
C: -5.08%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -1.9%
H: 1.38%
C: 1.21%
DUPIXENT (dupilumab injection) pre-filled pen now available in Canada, providing convenient self-administration option for people with type 2 inflammatory diseases
Published: 2021-06-17 (Crawled : 15:00) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.98%
H: 0.77%
C: 0.65%
disease injection dupixent
CytoReason Collaborates with Sanofi, Using its AI Technology to Gain Better Understanding of Disease Mechanisms
Published: 2021-06-17 (Crawled : 15:00) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.98%
H: 0.77%
C: 0.65%
disease technology collaboration air technology
Athletico Taps YOOBIC Digital Workplace to Enable Growth Aspirations
Published: 2021-06-17 (Crawled : 13:00) - prnewswire.com
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.98%
H: 0.77%
C: 0.65%
growth
Newly licensed US manufacturing facility to increase availability of Fluzone® High-Dose Quadrivalent (influenza vaccine)
Published: 2021-06-17 (Crawled : 12:00) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.98%
H: 0.77%
C: 0.65%
vaccine license influenza
Rancho Santa Fe Bio, Inc. Enters into Worldwide Exclusive License Agreement with Sanofi for Ataciguat
Published: 2021-06-17 (Crawled : 11:00) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.98%
H: 0.77%
C: 0.65%
license
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.